Inhibition by doxycycline of angiogenesis in the chicken chorioallantoic membrane (CAM) Mary RichardsonDavid WongGurmit Singh Original Article 22 February 2005 Pages: 1 - 9
Mitomycin-C and capecitabine as third-line chemotherapy in patients with advanced colorectal cancer: a phase II study Do Hyoung LimYoung Suk ParkKeunchil Park Original Article 22 March 2005 Pages: 10 - 14
A novel phospholipid gemcitabine conjugate is able to bypass three drug-resistance mechanisms Richard L. AlexanderBryan T. GreeneGregory L. Kucera Original Article 24 March 2005 Pages: 15 - 21
Effects of histone deacetylase inhibitor FR901228 on the expression level of telomerase reverse transcriptase in oral cancer Jun MurakamiJun-ichi AsaumiKanji Kishi Original Article 25 March 2005 Pages: 22 - 28
Pancratistatin causes early activation of caspase-3 and the flipping of phosphatidyl serine followed by rapid apoptosis specifically in human lymphoma cells Natasha KekreCarly GriffinSiyaram Pandey Original Article 22 February 2005 Pages: 29 - 38
A phase II study of flavopiridol in patients with advanced renal cell carcinoma: results of Southwest Oncology Group Trial 0109 Peter J. Van VeldhuizenJames R. FaulknerE. David. Crawford Original Article 25 March 2005 Pages: 39 - 45
Targeting BCL-2 overexpression in various human malignancies through NF-κB inhibition by the proteasome inhibitor bortezomib Bridget N. FahyMichael G. SchliemanRichard J. Bold Original Article 25 March 2005 Pages: 46 - 54
Hyperthermic isolated regional perfusion with CDDP for bone and soft-tissue sarcoma of the lower limb: pharmacokinetics, thermal dose, toxicity, and feasibility Satoshi AbeToru TokizakiTakashi Matsushita Original Article 25 March 2005 Pages: 55 - 62
American ginseng berry extract and ginsenoside Re attenuate cisplatin-induced kaolin intake in rats Sangeeta MehendaleHan AungChun-Su Yuan Original Article 25 March 2005 Pages: 63 - 69
In vivo antitumor activity by 2′,4′-dihydroxy-6′-methoxy-3′,5′-dimethylchalcone in a solid human carcinoma xenograft model Chun-Lin YeJian-Wen LiuFeng Qian Original Article 02 April 2005 Pages: 70 - 74
Phase I clinical and pharmacokinetic trial of docetaxel and irinotecan administered on a weekly schedule Agustin A. GarciaMahesh PujariStan Louie Original Article 05 April 2005 Pages: 75 - 82
Properties of recombinant human N1-acetylpolyamine oxidase (hPAO): potential role in determining drug sensitivity Yanlin WangAmy HackerRobert A. Casero Jr Original Article 25 March 2005 Pages: 83 - 90
Incidence and risk factors for paclitaxel hypersensitivity during ovarian cancer chemotherapy Toshiaki SendoNaoko SakaiRyozo Oishi Original Article 25 March 2005 Pages: 91 - 96
Opioid growth factor enhances tumor growth inhibition and increases the survival of paclitaxel-treated mice with squamous cell carcinoma of the head and neck Jeffrey R. JaglowskiIan S. ZagonPatricia J. McLaughlin Original Article 25 March 2005 Pages: 97 - 104
Therapeutic effect of tamoxifen and energy-modulating vitamins on carbohydrate-metabolizing enzymes in breast cancer Selvanathan Saravana PerumalPalanivelu ShanthiPanchanadham Sachdanandam Original Article 22 February 2005 Pages: 105 - 114